-
公开(公告)号:US06214876B1
公开(公告)日:2001-04-10
申请号:US08278441
申请日:1994-07-21
IPC分类号: A61K31195
CPC分类号: C07F9/3882 , C07C45/46 , C07C45/65 , C07C49/755 , C07C59/64 , C07C59/72 , C07C69/734 , C07C235/32 , C07C2602/08
摘要: Indene-1-acetamide compounds of the general formula (I) below; inhibit sPLA2 mediated release of fatty acids and are useful for treatment of conditions such as septic shock.
摘要翻译: 下面通式(I)的茚-1-乙酰胺化合物;抑制sPLA2介导的脂肪酸释放,可用于治疗诸如败血性休克的病症。
-
公开(公告)号:US06645976B1
公开(公告)日:2003-11-11
申请号:US08765566
申请日:1997-04-28
IPC分类号: C07D22104
CPC分类号: C07D471/04 , C07F9/6561
摘要: A class of novel indolizine-1-functional compounds and indolizine-3-functional compounds is disclosed together with the use of such indolizine compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock. The compounds are indolizine-1-acetamides, indolizine-1-acetic acid hydrazides, indolizine-1-glyoxylamides, indolizine-3-acetamides, indolizine-3-acetic acid hydraxides, and indolizine-3-glyoxylasides.
摘要翻译: 公开了一类新的中氮嗪-1-功能化合物和中氮嗪-3-功能化合物,以及使用这种中氮茚化合物来抑制sPLA2介导的脂肪酸释放以治疗诸如败血性休克的病症。 所述化合物为中氮茚-1-乙酰胺,中氮茚-1-乙酸酰肼,中氮茚-1-乙醛酰胺,中氮茚-3-乙酰胺,中氮茚-3-乙酸氢氧化物和中氮茚-3-乙醛酸酯。
-
公开(公告)号:US4916231A
公开(公告)日:1990-04-10
申请号:US377409
申请日:1989-07-10
申请人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Takaharu Matsuura , Sanji Hagishita , Kaoru Seno
发明人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Takaharu Matsuura , Sanji Hagishita , Kaoru Seno
IPC分类号: C07D257/04 , C07D493/08
CPC分类号: C07D257/04 , C07D493/08
摘要: Tetrazole derivatives represented by the formula: ##STR1## wherein R is naphthyl or phenyl optionally substituted by phenyl, lower alkyo, halogen, lower alkoxy, hydroxy or acetoxy; X is methylene, dimethylmethylene or oxygen; n is an integer of 0 or 1; and p and r each is an integer of 0 or 1 and q is an integer of 1 or 2 provided that p+q+r=2; or a tautomer in tetrazole ring and a pharmaceutically acceptable salt thereof, which are useful as TXA.sub.2 receptor antagonist.
-
公开(公告)号:US4861913A
公开(公告)日:1989-08-29
申请号:US927823
申请日:1986-11-05
申请人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Sanji Hagishita , Kaoru Seno , Susumu Kamata , Nobuhiro Haga , Tatsuo Tsuri , Tadahiko Tsushima , Kenji Kawada
发明人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Sanji Hagishita , Kaoru Seno , Susumu Kamata , Nobuhiro Haga , Tatsuo Tsuri , Tadahiko Tsushima , Kenji Kawada
IPC分类号: C07D493/08 , A61K31/00 , A61K31/335 , A61K31/336 , A61K31/34 , A61K31/557 , A61P7/02 , A61P9/08 , A61P11/08 , C07C20060101 , C07C67/00 , C07C301/00 , C07C311/00 , C07C311/02 , C07C311/07 , C07C311/10 , C07C311/13 , C07C311/15 , C07C311/20 , C07C311/37 , C07C313/00 , C07C323/52 , C07D209/52 , C07D209/56 , C07D213/34 , C07D213/71 , C07D221/22 , C07D303/40 , C07D303/46 , C07D331/02 , C07D491/044 , C07D493/04 , C07D495/04
CPC分类号: C07D493/08 , C07D213/34 , Y02P20/55
摘要: Bicyclic sulfonamido derivatives represented by the formula: ##STR1## wherein R.sub.1 is a hydrogen or lower alkyl; R.sub.2 is an alkyl, substituted or unsubstituted aryl, aralkyl or heterocycle; R.sub.3 is a hydrogen or methyl; X is an alkylene or alkenylene which may be substituted by a fluorine atom or atoms an may contain an oxygen, sulfur and/or phenylene in the chain; Y is straight or branched alkylene or alkenylene, oxygen, or sulfur; m is 0 or 1; and n is 0, 1 or 2, or their salt, said derivatives being useful as antithrombotic, anti-vasoconstricting, and anti-bronchoconstricting drugs.
摘要翻译: 由下式表示的双环磺酰氨基衍生物:其中R1是氢或低级烷基; R2是烷基,取代或未取代的芳基,芳烷基或杂环基; R3是氢或甲基; X是可以被氟原子或原子取代的亚烷基或亚烯基,链中可以含有氧,硫和/或亚苯基; Y是直链或支链亚烷基或亚烯基,氧或硫; m为0或1; 并且n为0,1或2或其盐,所述衍生物可用作抗血栓形成,抗血管收缩和抗支气管收缩药物。
-
公开(公告)号:US4976891A
公开(公告)日:1990-12-11
申请号:US327778
申请日:1989-03-23
申请人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Sanji Hagishita , Kaoru Seno , Susumu Kamata
发明人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Sanji Hagishita , Kaoru Seno , Susumu Kamata
IPC分类号: C07D493/08 , A61K31/00 , A61K31/335 , A61K31/336 , A61K31/34 , A61K31/557 , A61P7/02 , A61P9/08 , A61P11/08 , C07C20060101 , C07C67/00 , C07C301/00 , C07C311/00 , C07C311/02 , C07C311/07 , C07C311/10 , C07C311/13 , C07C311/15 , C07C311/20 , C07C311/37 , C07C313/00 , C07C323/52 , C07D209/52 , C07D209/56 , C07D213/34 , C07D213/71 , C07D221/22 , C07D303/40 , C07D303/46 , C07D331/02 , C07D491/044 , C07D493/04 , C07D495/04
CPC分类号: C07D493/08 , C07D213/34 , Y02P20/55
摘要: Bicyclic sulfonamido derivatives represented by the formula: ##STR1## wherein R.sub.1 is a hydrogen or lower alkyl; R.sub.2 is an alkyl, substituted or unsubstituted arly, aralkyl or hetelocycle; R.sub.3 is hydrogen or methyl; X is an alkylene or alkenylene which may be substituted by a fluorine atom or atoms and may contain an oxygen, sulfur and/or phenylene in the chain; Y is straight or branched alkylene or alkeneylene, oxygen, or sulfur; m is 0 or 1; and n is 0, 1 or 2, or their salt, said derivatives being useful as antithrombotic, anti-vasoconstricting, and anti-bronchoconstricting drugs.
-
公开(公告)号:US4960909A
公开(公告)日:1990-10-02
申请号:US327772
申请日:1989-03-23
申请人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Sanji Hagishita , Kaoru Seno , Susumu Kamata , Nobuhiro Haga , Tatsuo Tsuri , Tadahiko Tsushima , Kenji Kawada
发明人: Masayuki Narisada , Mitsuaki Ohtani , Fumihiko Watanabe , Sanji Hagishita , Kaoru Seno , Susumu Kamata , Nobuhiro Haga , Tatsuo Tsuri , Tadahiko Tsushima , Kenji Kawada
IPC分类号: C07D493/08 , A61K31/00 , A61K31/335 , A61K31/336 , A61K31/34 , A61K31/557 , A61P7/02 , A61P9/08 , A61P11/08 , C07C20060101 , C07C67/00 , C07C301/00 , C07C311/00 , C07C311/02 , C07C311/07 , C07C311/10 , C07C311/13 , C07C311/15 , C07C311/20 , C07C311/37 , C07C313/00 , C07C323/52 , C07D209/52 , C07D209/56 , C07D213/34 , C07D213/71 , C07D221/22 , C07D303/40 , C07D303/46 , C07D331/02 , C07D491/044 , C07D493/04 , C07D495/04
CPC分类号: C07D493/08 , C07D213/34 , Y02P20/55
摘要: Bicyclic sulfonamido derivatives represented by the formula: ##STR1## wherein R.sub.1 is a hydrogen or lower alkyl; R.sub.2 is an alkyl, substituted or unsubstituted aryl, aralkyl or hetelocycle; R.sub.3 is a hydrogen or methyl; X is an alkylene or alkenylene which may be substituted by a fluorine atom or atoms and may contain an oxygen, sulfur and/or phenylene in the chain; Y is straight or branched alkylene or alkenylene oxygen, or sulfur; m is 0 or 1; and n is 0, 1 or 2, or their salt, said derivatives being useful as antithrombotic, anti-vasoconstricting, and anti-bronchoconstricting drugs.
-
公开(公告)号:US5776929A
公开(公告)日:1998-07-07
申请号:US663304
申请日:1996-06-25
申请人: Sanji Hagishita , Susumu Kamata , Kaoru Seno , Nobuhiro Haga , Yasunobu Ishihara
发明人: Sanji Hagishita , Susumu Kamata , Kaoru Seno , Nobuhiro Haga , Yasunobu Ishihara
IPC分类号: C07D243/12 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/12 , C07D417/14 , A61K31/55
CPC分类号: C07D403/12 , C07D243/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/12 , C07D417/14
摘要: A benzodiazepine derivative of the formula (I): ##STR1## wherein R.sub.1 is a bond, --CH.sub.2 --, --CH.sub.2 O--, --SCH.sub.2 -- or a group of the formula: ##STR2## R.sub.2 is a lower alkyl, --COOR.sub.5, --CONH(CH.sub.2).sub.n COOR.sub.5, --CONHSO.sub.2 R.sub.5, --SO.sub.2 NHCOR.sub.5, or an optionally substituted heterocyclic group (R.sub.5 is a hydrogen atom, lower alkyl or benzyl and n is an integer of 1 to 5); R.sub.3 is a bond, --CO-- or --CONH--; and R.sub.4 is an optionally substituted heterocyclic group, optionally substituted lower alkyl, optionally substituted lower cycloalkyl, optionally substituted aryl, or lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof, which has a high affinity for gastrin receptors and/or CCK-B receptors but not for CCK-A receptors, and is useful for treating diseases associated with gastrin receptors and/or CCK-B receptors without inducing the side effects associated with CCK-A receptors.
摘要翻译: PCT No.PCT / JP94 / 02132 Sec。 371日期1996年6月25日第 102(e)日期1996年6月25日PCT 1994年12月19日PCT PCT。 公开号WO95 / 18110 日期:1995年7月6日一种式(I)的苯并二氮杂衍生物:其中R 1是一个键,-CH 2 - , - CH 2 O-,-SCH 2 - 或下式的基团: 低级烷基,-COOR 5,-CONH(CH 2)n COOR 5,-CONHSO 2 R 5,-SO 2 NHCOR 5或任选取代的杂环基(R 5为氢原子,低级烷基或苄基,n为1至5的整数)。 R3是键,-CO-或-CONH-; 并且R4是任选取代的杂环基,任选取代的低级烷基,任选取代的低级环烷基,任选取代的芳基或低级烷氧基羰基或其药学上可接受的盐,其对胃泌素受体和/或CCK-B受体具有高亲和力 但不适用于CCK-A受体,并且可用于治疗与胃泌素受体和/或CCK-B受体相关的疾病,而不诱导与CCK-A受体相关的副作用。
-
公开(公告)号:US4904819A
公开(公告)日:1990-02-27
申请号:US187645
申请日:1988-04-28
申请人: Sanji Hagishita , Kaoru Seno
发明人: Sanji Hagishita , Kaoru Seno
IPC分类号: A61K31/18 , C07C311/00 , C07C311/02 , C07C311/15
CPC分类号: A61K31/18 , C07C311/00 , C07C311/02 , C07C311/15
摘要: Bicyclic sulfonamide derivatives represented by the formula: ##STR1## (wherein R.sub.1 is hydrogen or lower alkyl; R.sub.2 is lower alkyl, aralkyl, or aryl which may be substituted by lower alkyl, alkoxy, acetoxy, hydroxy, halogen, nitro or phenyl; and the wavy line indicates R or S configuration or their mixture) or their salt being used as antithrombotic, antivasoconstricting, and antibronchoconstricting drugs and the process therefor.
-
公开(公告)号:US5739162A
公开(公告)日:1998-04-14
申请号:US687433
申请日:1996-08-09
申请人: Sanji Hagishita , Susumu Kamata , Yasushi Murakami , Nobuhiro Haga , Yasunobu Ishihara , Toshiro Konoike
发明人: Sanji Hagishita , Susumu Kamata , Yasushi Murakami , Nobuhiro Haga , Yasunobu Ishihara , Toshiro Konoike
IPC分类号: A61K31/17 , A61K38/00 , A61K38/05 , A61P1/04 , C07C275/28 , C07K5/06 , C07K5/062 , A61K31/24
CPC分类号: C07K5/0606 , C07C275/28 , C07K5/06026 , C07K5/06139 , A61K38/00
摘要: A compound of the formula (I): ##STR1## wherein R.sub.1 is a hydrogen atom or lower alkyl; R.sub.2 is a lower alkoxy, lower alkylamino, lower cycloalkyl, optionally substituted phenyl or optionally substituted heterocyclic group; R.sub.3 is an optionally substituted phenyl; R.sub.4 is an optionally substituted phenyl, optionally substituted cycloalkyl, optionally substituted alkyl or optionally substituted heterocyclic group, or a pharmaceutically acceptable salt thereof, which has a high affinity for gastrin receptors and/or CCK-B receptors but not for CCK-A receptors, and is useful for treating diseases associated with gastrin receptors and/or CCK-B receptors without inducing the side effects associated with CCK-A receptors.
摘要翻译: PCT No.PCT / JP95 / 00161 Sec。 371日期:1996年8月9日 102(e)日期1996年8月9日PCT提交1995年2月7日PCT公布。 WO95 / 21856 PCT公开 日期:1995年8月17日一种式(I)化合物:其中R 1是氢原子或低级烷基; R2是低级烷氧基,低级烷基氨基,低级环烷基,任意取代的苯基或任意取代的杂环基; R3是任选取代的苯基; R4是任选取代的苯基,任选取代的环烷基,任选取代的烷基或任选取代的杂环基,或其药学上可接受的盐,其对胃泌素受体和/或CCK-B受体具有高亲和力,但不对CCK-A受体具有高亲和力, 并且可用于治疗与胃泌素受体和/或CCK-B受体相关的疾病,而不诱导与CCK-A受体相关的副作用。
-
公开(公告)号:US5138067A
公开(公告)日:1992-08-11
申请号:US707164
申请日:1991-05-29
申请人: Susumu Kamata , Tatsuo Tsuri , Nobuhiro Haga , Takeaki Matsui , Morio Kishi , Kimio Takahashi , Sanji Hagishita , Kaoru Seno
发明人: Susumu Kamata , Tatsuo Tsuri , Nobuhiro Haga , Takeaki Matsui , Morio Kishi , Kimio Takahashi , Sanji Hagishita , Kaoru Seno
IPC分类号: C07C311/32 , C07C311/46 , C07C323/49 , C07C391/00 , C07D213/20 , C07D215/10 , C07D217/10 , C07D241/12 , C07D261/12 , C07D277/22 , C07D277/62 , C07D295/088 , C07D413/12 , C07D521/00
CPC分类号: C07D213/20 , C07C311/32 , C07C311/46 , C07C323/49 , C07C391/00 , C07D215/10 , C07D217/10 , C07D231/12 , C07D233/56 , C07D241/12 , C07D249/08 , C07D261/12 , C07D277/22 , C07D277/62 , C07D295/088 , C07D413/10
摘要: Lipid derivatives represented by the formula: ##STR1## wherein R.sub.1 is alkyl or alkylcarbamoyl; R.sub.2 is lower alkyloxy, lower alkylcarbamoyloxy, lower alkylcarbonylamino, lower alkyloxycarbonylamino, lower alkylureido, lower alkyloxymethyl, lower alkylcarbonylmethyl, cyanomethyl, heterocyclic group, or heterocyclyloxy; R.sub.2 ' is hydrogen or R.sub.2 and R.sub.2 ' taken together with R.sub.2 form --O(CH.sub.2).sub.m -- wherein m is an integer of 1 to 5; R.sub.3, R.sub.4, and R.sub.5 each is hydrogen or lower alkyl or two or three of R.sub.3, R.sub.4, and R.sub.5 taken together with the adjacent nitrogen atom form cyclic ammonio; R.sub.6 is hydrogen or lower alkylcarbonyl; X.sup.- is a counter anion; Y is oxygen or sulfur; and n is an integer of 1 to 10, being useful as PAF antagonists, e.g., as antithrombotic, antivasoconstricting, antibronchoconstricting agent or antitumor agent.
摘要翻译: 由下式表示的脂质衍生物:其中R1是烷基或烷基氨基甲酰基; 低级烷氧基羰基氨基,低级烷基脲基,低级烷氧基甲基,低级烷基羰基甲基,氰基甲基,杂环基或杂环氧基; R2'是氢或R2和R2'与R2一起形成-O(CH 2)m - ,其中m是1至5的整数; R 3,R 4和R 5各自为氢或低级烷基或R 3,R 4和R 5中的两个或三个与相邻的氮原子一起形成环状铵; R6是氢或低级烷基羰基; X-是抗衡阴离子; Y是氧或硫; n为1〜10的整数,可用作PAF拮抗剂,例如作为抗血栓形成,抗收缩性抗静电收缩剂或抗肿瘤剂。
-
-
-
-
-
-
-
-
-